Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading 7.2% Higher – Should You Buy?

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) shot up 7.2% during trading on Tuesday . The stock traded as high as $15.61 and last traded at $15.61. 427 shares traded hands during trading, a decline of 95% from the average session volume of 8,371 shares. The stock had previously closed at $14.56.

Wall Street Analyst Weigh In

TLX has been the subject of several recent analyst reports. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th. UBS Group started coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They set a “buy” rating and a $21.00 target price on the stock.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The business’s 50 day simple moving average is $15.61.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.